|
|
20. Intensive Diabetes
Care in the 21st Century Sunday,
September 17, 2000
14:00-17:30
| 14.00 |
Introduction
Prof. Geremia B. Bolli, University of Perugia |
| 14.05 |
The Rationale for using CSII in
T1DM
Prof. Geremia B. Bolli |
| 14.25 |
Longterm Experience with CSII
Terezie Pelikanova, M.D., Associate Professor of Medicine, Institute
for Clinical and Experimental Medicine, Prague |
| 14.55 |
Quality Management in Pump Therapy
Univ. Prof. Thomas Pieber, Medizinische Universitätsklinik Graz,
Diabetes-Ambulanz |
| 15.25 |
Break |
| 15.45 |
Disetronic's Novel Dialysis-Type
Glucose Sensor
as Prerequisite for an Artificial-Pancreas Solution
Prof. Bruno Reihl, Head of Research and Development, Disetronic |
| 16.15 |
Intraperitoneal Insulin
Therapy: Possibilities and Limitations
Dr. Andreas Liebl, Centre for Diabetes and Metabolism, Tegernsee
(Munich) |
| 16.35 |
First French Experience of DiaPort
System
in Type I Diabetic Patients (case report)
Dr. Laurence Kessler, Service d'Endocrinologie et de Diabètologie,
Hôpital Civil - Centre Hospitalier Universitaire, Strasburg |
| 16.45 |
Closing remarks
Prof. Geremia B. Bolli |
| 16.55 |
The Power of Choice - a Swiss
Cocktail |
Four Points Sheraton Hotel
Disetronic Medical Systems AG
 FOR
GENERAL, REGISTRATION AND ABSTRACT ENQUIRIES
Ursula Ledermann
Disetronic Medical Systems AG
Brunnmattstrasse 6, CH-3401 Burgdorf, SWITZERLAND
Tel: +41 34 427 1813
Fax: +41 34 427 1820
E-mail: ursula.ledermann@disetronic.ch
|
